Core Viewpoint - Sichuan Province is actively promoting the HPV vaccine through various initiatives aimed at improving public health, including expanding the target population, reducing vaccine costs, and optimizing service processes [1][2][3] Group 1: HPV Vaccine Promotion - The HPV vaccination program will begin in 2025 across several cities and counties in Sichuan, with specific measures such as extending the vaccination period and providing cost reductions for certain age groups [1] - Eligible individuals aged 9-26 years and 35-45 years for females, as well as 16-26 years for males, can receive a cost reduction for the final dose of the imported nine-valent HPV vaccine [1][2] - The vaccination schedule for girls aged 9-14 allows for a two-dose regimen where the first dose is charged and the second dose is free [1] Group 2: Health Impact and Statistics - The incidence of cervical cancer in China has been rising, with nearly 150,000 new cases and 60,000 deaths reported in 2022, highlighting the importance of preventive measures [2] - The World Health Organization emphasizes that cervical cancer is preventable, and the 2023 guidelines recommend health education and HPV vaccination as primary prevention strategies [2] Group 3: Guidelines and Recommendations - The "Clinical Application Guidelines for Preventive HPV Vaccines in China (2025 Edition)" recommend prioritizing HPV vaccination for females aged 9-26, particularly focusing on girls aged 9-14 [3] - The initiatives in Sichuan reflect a commitment to implementing scientific recommendations and aim to establish a herd immunity barrier by including males and other age groups in the vaccination program [3] - The policies are designed to enhance public willingness to vaccinate by lowering costs and improving service accessibility, with extended service periods and appointment windows [3]
守护民生健康 四川持续推进HPV疫苗惠民接种